Literature DB >> 19823793

[Drug interactions in geriatric medicine].

Angela Storka1, Johannes Pleiner.   

Abstract

Drug interactions are often seen in elder patients due to polymedication. They can lead to unwanted side effects attended with unspecific symptoms such as vertigo, lateropulsion, fatigue or confusion. This can result in a prescribing cascade. Interactions can take place on all pharmacodynamic and pharmacokinetic levels, whereas the CYP enzyme-dependent metabolism seems to play a key role. The incidence of drug interactions is quite high and clinical relevant interactions are also not uncommon. Especially drugs with a low therapeutic index are more likely to be the target of clinical relevant interactions. However, most of the drug interactions can be managed by dose-reduction or by replacing one of the possibly interacting drugs. An important point is to remember the possibility of drug interactions.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19823793     DOI: 10.1007/s10354-009-0708-2

Source DB:  PubMed          Journal:  Wien Med Wochenschr        ISSN: 0043-5341


  55 in total

1.  Interrelationship between substrates and inhibitors of human CYP3A and P-glycoprotein.

Authors:  R B Kim; C Wandel; B Leake; M Cvetkovic; M F Fromm; P J Dempsey; M M Roden; F Belas; A K Chaudhary; D M Roden; A J Wood; G R Wilkinson
Journal:  Pharm Res       Date:  1999-03       Impact factor: 4.200

Review 2.  An overview of psychotropic drug-drug interactions.

Authors:  Neil B Sandson; Scott C Armstrong; Kelly L Cozza
Journal:  Psychosomatics       Date:  2005 Sep-Oct       Impact factor: 2.386

Review 3.  Pharmacogenetic differences and drug-drug interactions in immunosuppressive therapy.

Authors:  Jill S Warrington; Leslie M Shaw
Journal:  Expert Opin Drug Metab Toxicol       Date:  2005-10       Impact factor: 4.481

Review 4.  Twenty years of biochemistry of human P450s: purification, expression, mechanism, and relevance to drugs.

Authors:  F P Guengerich; N A Hosea; A Parikh; L C Bell-Parikh; W W Johnson; E M Gillam; T Shimada
Journal:  Drug Metab Dispos       Date:  1998-12       Impact factor: 3.922

Review 5.  Altered pharmacokinetics in the elderly.

Authors:  G J Yuen
Journal:  Clin Geriatr Med       Date:  1990-05       Impact factor: 3.076

Review 6.  Appropriate choice of proton pump inhibitor therapy in the prevention and management of NSAID-related gastrointestinal damage.

Authors:  G Singh; G Triadafilopoulos
Journal:  Int J Clin Pract       Date:  2005-10       Impact factor: 2.503

Review 7.  Evaluation of omeprazole, lansoprazole, pantoprazole, and rabeprazole in the treatment of acid-related diseases.

Authors:  L S Welage; R R Berardi
Journal:  J Am Pharm Assoc (Wash)       Date:  2000 Jan-Feb

Review 8.  Functional interactions between P-glycoprotein and CYP3A in drug metabolism.

Authors:  Uwe Christians; Volker Schmitz; Manuel Haschke
Journal:  Expert Opin Drug Metab Toxicol       Date:  2005-12       Impact factor: 4.481

Review 9.  Interactions between grapefruit juice and cardiovascular drugs.

Authors:  David G Bailey; George K Dresser
Journal:  Am J Cardiovasc Drugs       Date:  2004       Impact factor: 3.571

10.  Interaction between grapefruit juice and midazolam in humans.

Authors:  H H Kupferschmidt; H R Ha; W H Ziegler; P J Meier; S Krähenbühl
Journal:  Clin Pharmacol Ther       Date:  1995-07       Impact factor: 6.875

View more
  1 in total

1.  Association of anemia with functional and nutritional status in the German multicenter study "GeriAnaemie2013".

Authors:  Gabriele Röhrig; Ymkje Rücker; Ingrid Becker; Ralf-Joachim Schulz; Romana Lenzen-Großimlinghaus; Peter Willschrei; Sybille Gebauer; Mirja Modreker; Martin Jäger; Rainer Wirth
Journal:  Z Gerontol Geriatr       Date:  2016-06-30       Impact factor: 1.281

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.